Profile data is unavailable for this security.
About the company
Carl Zeiss Meditec AG is a Germany-based medical technology and device company. The Company offers complete solutions to diagnose and treat ophthalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: ophthalmic devices and microsurgery. The Ophthalmic Devices segment comprises activities in ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiation. Its products include zeiss corneal photographers, slit lamps and accessories, data management software, zeiss intraocular lenses, optical biometers, optical coherence tomography systems, ophthalmic microscopes, refractive lasers are among others. The Company offers related support services.
- Revenue in EUR (TTM)2.20bn
- Net income in EUR120.62m
- Incorporated1995
- Employees5.78k
- LocationCarl Zeiss Meditec AGGoeschwitzer Strasse 51-52JENA 07745GermanyDEU
- Phone+49 3 641220331
- Fax+49 3 641220117
- Websitehttps://www.zeiss.de/meditec-ag/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gerresheimer AG | 2.25bn | 23.35m | 687.00m | 13.54k | 29.42 | 0.4901 | 2.46 | 0.3053 | 0.676 | 0.676 | 65.15 | 40.59 | 0.5455 | 3.73 | 7.85 | 185,328.90 | 0.6341 | 3.30 | 0.8716 | 4.68 | 26.89 | 30.04 | 1.16 | 5.84 | 0.5214 | 2.08 | 0.6022 | 41.29 | 2.28 | 7.90 | -5.52 | 6.32 | 17.58 | -49.35 |
| Paul Hartmann AG | 2.43bn | 81.51m | 782.36m | 10.09k | 9.54 | 0.6635 | 4.06 | 0.3224 | 22.95 | 22.95 | 682.93 | 330.05 | 1.16 | 1.97 | 5.54 | 240,745.70 | 4.12 | 4.21 | 5.45 | 5.79 | 59.56 | 57.30 | 3.56 | 3.35 | 1.11 | 14.11 | 0.2465 | 37.95 | 2.32 | 1.95 | 281.58 | 13.23 | 10.08 | 2.71 |
| Eckert & Ziegler SE | 304.47m | 40.62m | 950.20m | 1.11k | 23.14 | 4.04 | 16.64 | 3.12 | 0.6465 | 0.6328 | 4.85 | 3.70 | 0.6527 | 3.48 | 6.10 | 280,619.30 | 8.85 | 8.62 | 11.06 | 10.43 | 47.25 | 48.53 | 13.55 | 14.18 | 2.37 | 68.35 | 0.166 | 32.12 | 20.22 | 10.63 | 33.40 | 12.70 | 18.84 | 3.30 |
| Draegerwerk AG & Co KGaA | 3.42bn | 120.88m | 1.49bn | 16.68k | 10.85 | 0.8689 | 5.55 | 0.4344 | 6.45 | 6.45 | 182.35 | 80.56 | 1.13 | 2.51 | 5.01 | 206,009.00 | 4.00 | 3.72 | 5.94 | 5.59 | 45.35 | 44.54 | 3.53 | 3.49 | 1.03 | 7.96 | 0.1637 | 16.12 | -0.0778 | 3.92 | 12.65 | 37.91 | 0.4683 | 59.64 |
| SCHOTT Pharma AG & Co KgaA | 996.56m | 150.74m | 2.26bn | 4.81k | 14.94 | 2.43 | 9.44 | 2.26 | 1.00 | 1.00 | 6.63 | 6.18 | 0.6414 | 3.95 | 3.98 | 207,141.30 | 9.74 | 11.86 | 13.61 | 16.87 | 33.68 | 34.65 | 15.18 | 15.68 | 1.17 | -- | 0.0824 | 10.95 | 3.04 | 11.04 | -2.16 | 13.58 | 11.15 | -- |
| Carl Zeiss Meditec AG | 2.20bn | 120.62m | 2.40bn | 5.78k | 19.51 | -- | -- | 1.09 | 1.37 | 1.37 | 25.58 | -- | -- | -- | -- | 381,084.40 | -- | 8.00 | -- | 9.78 | 52.19 | 56.02 | 5.53 | 11.56 | -- | 7.38 | -- | 33.14 | 7.82 | 10.78 | -20.99 | 2.90 | 11.23 | 1.92 |
| Ottobock SE & Co KgaA | 1.64bn | 57.90m | 3.67bn | -- | 63.44 | 16.05 | 19.28 | 2.24 | 0.9048 | 0.9048 | 25.67 | 3.58 | -- | -- | -- | -- | -- | -- | -- | -- | 52.42 | -- | 3.42 | -- | 0.6458 | 3.18 | 0.8358 | -- | 7.33 | -- | -38.37 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| Capital Research & Management Co. (World Investors)as of 21 Jan 2026 | 3.16m | 3.54% |
| Invesco Advisers, Inc.as of 31 Dec 2025 | 1.93m | 2.16% |
| Union Investment Privatfonds GmbHas of 30 Sep 2025 | 1.32m | 1.48% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 1.31m | 1.46% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 1.18m | 1.32% |
| M&G Investment Management Ltd.as of 31 Oct 2025 | 835.19k | 0.93% |
| BlackRock Asset Management Deutschland AGas of 06 Feb 2026 | 716.86k | 0.80% |
| Candriam Belgium SAas of 31 Dec 2025 | 590.98k | 0.66% |
| Allianz Global Investors GmbHas of 31 Oct 2025 | 565.76k | 0.63% |
| Rathbones Asset Management Ltd.as of 31 Dec 2025 | 551.88k | 0.62% |
